6533b822fe1ef96bd127d338

RESEARCH PRODUCT

PCV81 Lifetime costs and life-years gained associated with apixaban, dabigatran, rivaroxaban, and warfarin for stroke prevention in atrial fibrillation

A.r. HarringtonE.p. ArmstrongP. NolanD.c. Malone

subject

10.1016/j.jval.2013.03.1483http://dx.doi.org/10.1016/j.jval.2013.03.1483